Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment

Jun 11, 2008

University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in Molecular Microbiology. The findings suggest a possible reason why human tuberculosis (TB) requires months of intensive antibiotic treatment and indicate a potential cause of the relapses that can nonetheless occur.

The researchers are the first to show that Mycobacterium tuberculosis can grow in surface-level bacteria clusters known as biofilms that are common in nature but never before shown for TB bacteria, explained the paper's senior author Graham Hatfull, chair and Eberly Family Professor of Biological Sciences in Pitt's School of Arts and Sciences. Hatfull collaborated and coauthored the paper with Professor William Jacobs Jr. of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine in New York.

Hatfull, Jacobs, and their colleagues found that the biofilm bacteria are physiologically and genetically different from TB bacteria harvested in a lab—the type used in developing antibiotics. These variations result in a population of the bacteria that are "drug-tolerant and harbor persistent cells that survive high concentrations of anti-tuberculosis antibiotics," the team reports.

People with TB typically undergo six to nine months of treatment with multiple antibiotics and most of the bacteria generally die within the first two weeks. Yet the disease can recur, presumably because of drug-tolerant bacteria that have escaped the antibiotic. The source and location of these persistent cells are unknown, but Hatfull and Jacobs' research reveals a possible biofilm origin, Jacobs said.

"The nature of persisting M. tuberculosis cells has been an enigma for the entire field," Jacobs said. "Clearly M. tuberculosis cells in biofilms represent at least one class of persistent cells, and we are testing their biological relevance."

It is not yet known whether the biofilm actually factors into human TB infections, Hatfull said. He added that the only similar research regarding biofilm in living creatures showed the presence of biofilm-like or biofilm-related bacteria in guinea pigs.

"While our data does not show conclusively that biofilm formation in people gives rise to a drug-tolerant population, the fact that biofilms do so in the lab makes this an interesting and testable hypothesis," Hatfull said.

Source: University of Pittsburgh

Explore further: Breaking down DNA by genome

add to favorites email to friend print save as pdf

Related Stories

Researchers Find Source of Drug-Tolerant Tuberculosis

Jun 12, 2008

University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported ...

Recommended for you

Breaking down DNA by genome

7 hours ago

New DNA sequencing technologies have greatly advanced genomic and metagenomic studies in plant biology. Scientists can readily obtain extensive genetic information for any plant species of interest, at a relatively low cost, ...

Is fleet diversity key to sustainable fisheries?

14 hours ago

Concern about fisheries is widespread around the world. Over the past several decades, a robust discussion has taken place concerning how to manage fisheries better to benefit ecosystems and humans. Much of the discussion ...

Strange, fanged deer persists in Afghanistan

14 hours ago

More than 60 years after its last confirmed sighting, a strange deer with vampire-like fangs still persists in the rugged forested slopes of northeast Afghanistan according to a research team led by the Wildlife ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.